Company Data
PainReform Ltd.
Ticker
PRFX
Current Price
$0.92 -2.64%
Market Cap
$1.6M
Price Target
Refer to Report
Volume
24.6K
52wk Range
$0.69 - $26.41
Overview
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company’s product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.